HomeGeneticsConditionMitochondrial complex V deficiency
Back to Condition
Mitochondrial complex V deficiency
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Condition

Mitochondrial complex V deficiency

Mitochondrial complex V deficiency is a disorder caused by a shortage or loss of function in a protein complex essential for cellular energy production, often leading to severe neurological and cardiac complications.

Overview

Mitochondrial complex V deficiency is a shortage or loss of function of a protein complex called complex V. This complex is found in cell structures called mitochondria, which convert energy from food into a form cells can use. Complex V is the final of five mitochondrial complexes that carry out oxidative phosphorylation, a multistep process through which cells derive much of their energy.

Symptoms

The disorder can cause a wide variety of signs and symptoms affecting many organs, particularly the nervous system and the heart. It can be life-threatening in infancy or early childhood. Common features include:

  • Feeding problems and slow growth
  • Low muscle tone (hypotonia)
  • Extreme fatigue (lethargy) and developmental delay
  • Elevated levels of lactic acid in the blood (lactic acidosis), causing nausea, vomiting, weakness, and rapid breathing
  • High levels of ammonia in the blood (hyperammonemia), which can lead to abnormal brain function (encephalopathy)
  • Hypertrophic cardiomyopathy (thickening of the heart muscle that can lead to heart failure)
  • Characteristic facial features, including a high forehead, curved eyebrows, downward-slanting eyes, a prominent nasal bridge, low-set ears, thin lips, and a small chin

Specific Syndromes

  • NARP (Neuropathy, ataxia, and retinitis pigmentosa): Affects the nervous system, causing numbness, tingling, or pain in the arms and legs (sensory neuropathy), muscle weakness, balance and coordination problems (ataxia), cognitive impairment, and vision loss.
  • Leigh syndrome: Characterized by progressive loss of mental and movement abilities (developmental or psychomotor regression), typically resulting in death within 2 to 3 years of symptom onset.

Causes & Risk Factors

The condition is caused by mutations in several genes that provide instructions for making components of complex V or proteins that help assemble it. These mutations impair the formation or function of complex V, reducing oxidative phosphorylation and potentially leading to cell death in high-energy tissues like the nervous system, heart, liver, kidneys, and skeletal muscles.

  • Nuclear DNA: The TMEM70 gene is the most commonly mutated nuclear gene; it helps assemble and stabilize complex V.
  • Mitochondrial DNA (mtDNA): Mutations in mtDNA can be present in all (homoplasmy) or some (heteroplasmy) of the mitochondria, with higher percentages of mutated mtDNA typically leading to more severe disease.

Inheritance

  • Autosomal Recessive: When caused by nuclear DNA mutations, both copies of the gene in each cell must have mutations. Parents are typically unaffected carriers.
  • Maternal Inheritance: When caused by mtDNA mutations, the condition is passed only from mothers to their children, as egg cells contribute mitochondria to the developing embryo.

Frequently Asked Questions

Watch for rapid breathing, persistent vomiting, unexplained lethargy, irritability, and a sudden drop in appetite. A blood test showing elevated lactate confirms the problem, but these clinical clues should prompt you to call your pediatrician or go to the emergency department promptly.
high‑carbohydrate, low‑fat diet can reduce reliance on fatty‑acid oxidation, which is impaired. Some clinicians add a “mitochondrial cocktail” that may include coenzyme Q10 (30–50 mg/kg/day divided doses), riboflavin (100–400 mg/day), and L‑carnitine (50 mg/kg/day). Always discuss dosing with a metabolic specialist before starting any supplement.
If your child develops sudden confusion, a change in mental status, seizures, or a worsening of vomiting and lethargy, treat it as an emergency. Hyperammonemia can progress to cerebral edema quickly, so call emergency services or go to the nearest hospital for immediate ammonia‑lowering therapy (e.g., sodium benzoate, arginine) and intensive monitoring.
Management focuses on standard heart‑failure drugs such as beta‑blockers or ACE inhibitors, tailored to the child’s blood pressure and heart rate. Some centers use dichloroacetate or bezafibrate to improve mitochondrial metabolism, but evidence is limited. Regular cardiac imaging and consultation with a pediatric cardiologist experienced in metabolic cardiomyopathies are essential.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA